Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × ulixertinib × 90 days × Clear all

Sponsor

Conditions

Glioma 4 Colorectal Neoplasms 3 Wilms Tumor 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Multiple Myeloma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Esophageal Neoplasms 2 Ependymoma 2 Carcinoma, Hepatocellular 2 Xanthogranuloma, Juvenile 1 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1

Interventions

Injections 5 pembrolizumab 4 Bevacizumab 4 Pemetrexed 3 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 Docetaxel 3 Carboplatin 3 trifluridine tipiracil drug combination 2 sotorasib 2 fludarabine 2 Paclitaxel 2 Drug Therapy 2 Cyclophosphamide 2 Cetuximab 2 trametinib 1 toripalimab 1 tislelizumab 1 palbociclib 1 olaparib 1 netrin-1 inhibitor NP137 1 cemiplimab 1 Panitumumab 1 Nivolumab 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 HMPL-013 1 Fulvestrant 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡